Pharmacological vitreolysis and posterior vitreous detachment

Related authors

• Leonardo Bruno Oliveira
• Rodrigo Jorge
• Rogério Alves Costa
• José Augusto Cardillo
• Rubens Camargo Siqueira

Related articles

• Results of office-based fluid–air exchange for postvitrectomy hemorrhage in diabetic retinopathy
• Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters
• Estimating the volume of the vitrectomized space using axial length: a guideline
• Ocular manifestation of vertical transmission of dengue: case report
• Visual outcomes and prognostic factors following 23G vitrectomy for vitreous hemorrhage in eyes with proliferative diabetic retinopathy
• Dose adjustment of intravitreal medications and gases according to axial length and vitreous cavity volume
• Vitreous metastasis from cutaneous melanoma: diagnosis and management
• The development of epiretinal membrane following rhegmatogenous retinal detachment repair: incidence, risk factors, and outcomes
• Macular edema after surgery to treat rhegmatogenous retinal detachment: 1-year follow-up, incidence, and associated risk factors
• A novel predictor of persistent ocular hypotony after pars plana vitrectomy for rhegmatogenous retinal detachment: The initial intraocular pressure difference between the eye with RRD and the fellow eye

Click here to search